A detailed history of National Asset Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, National Asset Management, Inc. holds 300,673 shares of PFE stock, worth $8.04 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
300,673
Previous 365,151 17.66%
Holding current value
$8.04 Million
Previous $10.2 Million 14.83%
% of portfolio
0.25%
Previous 0.27%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 13, 2024

SELL
$27.7 - $31.39 $1.79 Million - $2.02 Million
-64,478 Reduced 17.66%
300,673 $8.7 Million
Q2 2024

Aug 19, 2024

BUY
$25.26 - $29.6 $946,113 - $1.11 Million
37,455 Added 11.43%
365,151 $10.2 Million
Q1 2024

May 16, 2024

BUY
$25.89 - $29.73 $1.27 Million - $1.46 Million
49,129 Added 17.64%
327,696 $9.09 Million
Q4 2023

Mar 15, 2024

SELL
$26.13 - $33.94 $1.28 Million - $1.67 Million
-49,129 Reduced 14.99%
278,567 $8.02 Million
Q3 2023

Dec 01, 2023

SELL
$32.09 - $37.51 $34,593 - $40,435
-1,078 Reduced 0.33%
327,696 $10.9 Million
Q2 2023

Jul 27, 2023

SELL
$36.12 - $41.79 $716,079 - $828,486
-19,825 Reduced 5.69%
328,774 $12.1 Million
Q1 2023

May 17, 2023

BUY
$39.39 - $51.28 $92,724 - $120,713
2,354 Added 0.68%
348,599 $14.2 Million
Q4 2022

Mar 15, 2023

SELL
$41.75 - $54.5 $687,330 - $897,233
-16,463 Reduced 4.54%
346,245 $17.7 Million
Q4 2022

Feb 21, 2023

BUY
$41.75 - $54.5 $1.07 Million - $1.4 Million
25,677 Added 7.62%
362,708 $18.6 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $6.19 Million - $7.56 Million
141,534 Added 72.4%
337,031 $14.8 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $1.06 Million - $1.26 Million
-22,867 Reduced 10.47%
195,497 $10.3 Million
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $5.98 Million - $7.42 Million
-130,802 Reduced 37.46%
218,364 $11.3 Million
Q4 2021

Jan 28, 2022

SELL
$41.32 - $61.25 $19,627 - $29,093
-475 Reduced 0.14%
349,166 $20.6 Million
Q3 2021

Nov 16, 2021

BUY
$39.25 - $50.42 $597,502 - $767,543
15,223 Added 4.55%
349,641 $15 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $3.35 Million - $3.8 Million
93,382 Added 38.74%
334,418 $13.1 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $2.6 Million - $2.93 Million
77,592 Added 47.47%
241,036 $8.74 Million
Q4 2020

Feb 04, 2021

SELL
$33.47 - $42.56 $563,467 - $716,497
-16,835 Reduced 9.34%
163,444 $6.02 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $1.65 Million - $1.93 Million
51,913 Added 40.44%
180,279 $6.49 Million
Q2 2020

Jul 31, 2020

BUY
$30.12 - $36.54 $47,770 - $57,952
1,586 Added 1.25%
128,366 $4.2 Million
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $303,384 - $433,470
-11,224 Reduced 8.13%
126,780 $4.14 Million
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $300,263 - $340,760
9,121 Added 7.08%
138,004 $5.41 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $877,392 - $1.14 Million
27,005 Added 26.51%
128,883 $4.63 Million
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $573,855 - $644,307
15,518 Added 17.97%
101,878 $4.42 Million
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $10,687 - $11,742
-285 Reduced 0.33%
86,360 $3.67 Million
Q4 2018

Feb 08, 2019

BUY
$38.47 - $43.86 $39,893 - $45,482
1,037 Added 1.21%
86,645 $3.79 Million
Q3 2018

Nov 08, 2018

BUY
$34.47 - $41.81 $193,893 - $235,181
5,625 Added 7.03%
85,608 $3.78 Million
Q2 2018

Oct 05, 2018

BUY
$32.98 - $35.16 $71,797 - $76,543
2,177 Added 2.8%
79,983 $2.9 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $1.01 Million - $1.17 Million
-31,674 Reduced 28.93%
77,806 $2.76 Million
Q4 2017

Feb 15, 2018

BUY
$33.26 - $35.29 $7,184 - $7,622
216 Added 0.2%
109,480 $3.97 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $34,844 - $38,384
1,124 Added 1.04%
109,264 $3.9 Million
Q2 2017

Aug 15, 2017

BUY
N/A
108,140
108,140 $3.64 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.